5551 - 5560 of 7816 Results
Title
Year
-
RESTRICTEDTitle: Unraveling the role of motoneuron autophagy in ALSJournal Name: AutophagyPublisher: Informa UK LimitedVol: 14Issue #: 4Start Page: 733End Page: 737Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/15548627.2018.1432327Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2018.1432327?needAccess=trueCitation Count: 14
-
RESTRICTEDTitle: PET Imaging of Microglial Activation—Beyond Targeting TSPOJournal Name: MoleculesPublisher: MDPI AGVol: 23Issue #: 3Start Page: 607End Page: 607Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules23030607Best OA location URL: https://www.mdpi.com/1420-3049/23/3/607/pdf?version=1520494801Citation Count: 88
-
RESTRICTEDTitle: The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptorJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1100-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1100-1Citation Count: 118
- Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease2018RESTRICTEDTitle: Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 13Issue #: 3Start Page: e0192497End Page: e0192497Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0192497Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0192497&type=printableCitation Count: 21
-
RESTRICTEDTitle: Cerebral blood flow predicts differential neurotransmitter activityJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-22444-0Best OA location URL: https://www.nature.com/articles/s41598-018-22444-0.pdfCitation Count: 105
-
RESTRICTEDTitle: Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 5Start Page: 762End Page: 770Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27301Citation Count: 71
-
RESTRICTEDTitle: Assessment of an Objective Method of Dyskinesia Measurement in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 160End Page: 164Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12583Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12583Citation Count: 3
- Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice2018RESTRICTEDTitle: Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in MiceJournal Name: EBioMedicinePublisher: Elsevier BVVol: 29Issue #:Start Page: 13End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2018.01.035Best OA location URL: http://www.thelancet.com/article/S2352396418300392/pdfCitation Count: 28
-
RESTRICTEDTitle: CLIPPERS: A Treatable Cause of Spastic AtaxiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 212End Page: 214Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12602Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12602Citation Count: 2
- DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.2018RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20